XML 19 R8.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 24, 2025
Sep. 25, 2024
Cash flows from operating activities:    
Net income $ 3,428 $ 14,775
Adjustments to reconcile net income to cash flows provided by operating activities:    
Depreciation and amortization 12,919 10,938
Goodwill impairment charges 0 20
Operating (gains), losses and other charges, net 4,482 1,984
Amortization on interest rate swaps, net 2,051 502
Amortization of deferred financing costs 478 477
Gains on investments (36) (121)
Gains on early termination of debt and leases (8) (42)
Deferred income tax expense (benefit) 844 (1,672)
Increase of tax valuation allowance 423 333
Share-based compensation expense 9,016 8,406
Changes in assets and liabilities, excluding acquisitions and dispositions:    
Receivables 8,055 4,119
Inventories (286) 341
Prepaids and other current assets (1,597) 2,245
Other noncurrent assets (4,334) 669
Operating lease assets and liabilities (416) (725)
Accounts payable 5,996 (11,087)
Other accrued liabilities (8,840) (7,824)
Other noncurrent liabilities (1,833) (2,391)
Net cash flows provided by operating activities 30,342 20,947
Cash flows from investing activities:    
Capital expenditures (25,649) (17,710)
Acquisition of restaurants (4,105) 0
Proceeds from asset sales 3,486 1,360
Investment purchases 0 (1,500)
Proceeds from sale of investments 1,142 0
Collections on notes receivable 784 489
Issuance of notes receivable (767) (255)
Net cash flows used in investing activities (25,109) (17,616)
Cash flows from financing activities:    
Revolver borrowings 79,800 91,900
Revolver payments (81,600) (86,400)
Repayments of finance leases (921) (1,056)
Tax withholding on share-based payments (1,006) (1,881)
Purchase of treasury stock (1,668) (11,266)
Net bank overdrafts 688 1,945
Net cash flows used in financing activities (4,707) (6,758)
Increase (decrease) in cash and cash equivalents 526 (3,427)
Cash and cash equivalents at beginning of period 1,698 4,893
Cash and cash equivalents at end of period $ 2,224 $ 1,466